First randomized controlled trial to evaluate direct transition from multiple daily injections to automated insulin delivery in adults and children with type 1 diabetes who were not meeting glycemic ...

ACTON, Mass., March 19, 2025--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the ...

ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...

Compared with standard care, a closed-loop insulin delivery system increased the time spent within the pregnancy-specific glucose target range between 16 and 34 weeks 6 days ’ gestation among pregnant ...

Medical research: Insulin delivery system may aid adolescents with type 1 diabetes 概念実証を目的とした予備研究が実施され、ハイブリッド型クローズドループ技術を搭載したインスリン送達システムが、1型糖尿病の青年の高血糖と血糖変動を抑制し、脳の発達と認知機能を ...

Bhilai, Aug 21(IANS) A team of researchers from the Indian Institutes of Technology (IIT) Bhilai has successfully engineered a novel hydrogel-based insulin-delivery platform, which can help patients ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Children and adults had an improvement in time in range ...

Ottawa, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The global insulin delivery systems market size was estimated at USD 17.77 billion in 2024 and is expected to grow to about USD 38.09 billion by 2034, ...

株式会社グローバルインフォメーション（所在地：神奈川県川崎市、代表者：樋口 荘祐、証券コード：東証スタンダード 4171）は、市場調査レポート「インスリンデリバリーシステムの世界市場」（Global Industry Analysts, Inc.）の販売を7月18日より開始いたし ...